Could Eli Lilly's Next Weight Loss Drug Waylay Wegovy -- and Even Zap Zepbound? - Yahoo Finance
Could Eli Lilly's Next Weight Loss Drug Waylay Wegovy -- and Even Zap Zepbound? Yahoo Finance
Zepbound News
Why Zepbound Became the First Drug FDA-Cleared Specifically for Obstructive Sleep Apnea - Charlotte Observer
Why Zepbound Became the First Drug FDA-Cleared Specifically for Obstructive Sleep Apnea Charlotte Observer
A new Medicare option for weight loss drugs is coming: Here's what to know - NPR
A new Medicare option for weight loss drugs is coming: Here's what to know NPR
Zepbound’s and Ozempic’s greatest benefit may be their anti-inflammatory power - Scientific American
Zepbound’s and Ozempic’s greatest benefit may be their anti-inflammatory power Scientific American
Eli Lilly blows past quarterly estimates, hikes outlook as Zepbound and Mounjaro sales skyrocket - CNBC
Eli Lilly blows past quarterly estimates, hikes outlook as Zepbound and Mounjaro sales skyrocket CNBC
Restrictions on obesity drug coverage force patients to pivot - NPR
Restrictions on obesity drug coverage force patients to pivot NPR
Quit a GLP-1? Plan to start again? It's not recommended, but plenty of people do it - NPR
Quit a GLP-1? Plan to start again? It's not recommended, but plenty of people do it NPR
FDA approves Eli Lilly's GLP-1 pill, opening the next phase of the weight loss drug market - CNBC
FDA approves Eli Lilly's GLP-1 pill, opening the next phase of the weight loss drug market CNBC
Lilly's Foundayo and lower-dose Zepbound helped people maintain weight loss after switching from higher doses of injectable incretin therapy in two late-phase trials - investor.lilly.com
Lilly's Foundayo and lower-dose Zepbound helped people maintain weight loss after switching from higher doses of injectable incretin therapy in two late-phase trials investor.lilly.com
Zepbound Side Effects: Risks, Injuries & Lawsuit Updates - Motley Rice
Zepbound Side Effects: Risks, Injuries & Lawsuit Updates Motley Rice
Eli Lilly Says Newly Approved Foundayo, Lower-Dose Zepbound Help Sustain Weight Loss - Yahoo Finance
Eli Lilly Says Newly Approved Foundayo, Lower-Dose Zepbound Help Sustain Weight Loss Yahoo Finance
A Guide to Medicare’s New Coverage for Obesity Drugs - The New York Times
A Guide to Medicare’s New Coverage for Obesity Drugs The New York Times
Lilly data point to ‘maintenance’ strategies for GLP-1 weight loss - BioPharma Dive
Lilly data point to ‘maintenance’ strategies for GLP-1 weight loss BioPharma Dive
Lilly maintains weight loss leadership as Foundayo, Zepbound keep pounds off after switching - BioSpace
Lilly maintains weight loss leadership as Foundayo, Zepbound keep pounds off after switching BioSpace
Lilly's Foundayo, lower-dose Zepbound help sustain weight lost after higher-dose injectables - FirstWord Pharma
Lilly's Foundayo, lower-dose Zepbound help sustain weight lost after higher-dose injectables FirstWord Pharma
Patients don't regain much weight switching from injections to Lilly's weight-loss pill, study finds - Reuters
Patients don't regain much weight switching from injections to Lilly's weight-loss pill, study finds Reuters
Eli Lilly’s Foundayo and Lower-Dose Zepbound Helped Maintain Weight Loss in Patients Switching from Injectables - Pharmaceutical Executive
Eli Lilly’s Foundayo and Lower-Dose Zepbound Helped Maintain Weight Loss in Patients Switching from Injectables Pharmaceutical Executive
Novo, Lilly tout respective early response and weight loss maintenance data as GLP-1 rivalry intensifies - Fierce Pharma
Novo, Lilly tout respective early response and weight loss maintenance data as GLP-1 rivalry intensifies Fierce Pharma
Could Eli Lilly's Next Weight Loss Drug Waylay Wegovy -- and Even Zap Zepbound? - The Motley Fool
Could Eli Lilly's Next Weight Loss Drug Waylay Wegovy -- and Even Zap Zepbound? The Motley Fool
‘Next-Gen’ GLP-1 Leads to 16% More Weight Loss. Is It Better Than Zepbound? - Healthline
‘Next-Gen’ GLP-1 Leads to 16% More Weight Loss. Is It Better Than Zepbound? Healthline
Media Statement: Zepbound (tirzepatide) KwikPen now available at self-pay pricing at major pharmacies nationwide in addition to LillyDirect - investor.lilly.com
Media Statement: Zepbound (tirzepatide) KwikPen now available at self-pay pricing at major pharmacies nationwide in addition to LillyDirect investor.lilly.com
Zepbound (tirzepatide), the most prescribed weight management medication in 2025, now available in multi-dose KwikPen - investor.lilly.com
Zepbound (tirzepatide), the most prescribed weight management medication in 2025, now available in multi-dose KwikPen investor.lilly.com
Mounjaro, Zepbound Lowers Risk of Cardiovascular Death by 62% - Healthline
Mounjaro, Zepbound Lowers Risk of Cardiovascular Death by 62% Healthline
Lilly points to low-dose Zepbound and Foundayo as weight loss maintenance options - Endpoints News
Lilly points to low-dose Zepbound and Foundayo as weight loss maintenance options Endpoints News
Tirzepatide Injections for Sleep Apnea - GoodRx
Tirzepatide Injections for Sleep Apnea GoodRx
Publix Pharmacy provides access to savings on GLP-1 Zepbound multi-dose KwikPen - Publix
Publix Pharmacy provides access to savings on GLP-1 Zepbound multi-dose KwikPen Publix
Eli Lilly's Obesity Boom Leaves Little Room for Error - TradingView
Eli Lilly's Obesity Boom Leaves Little Room for Error TradingView
Eli Lilly cuts cash prices of Zepbound weight loss drug vials on direct-to-consumer site - CNBC
Eli Lilly cuts cash prices of Zepbound weight loss drug vials on direct-to-consumer site CNBC
Quitting weight-loss drugs or a diet can cause weight regain—two strategies could help prevent that - Scientific American
Quitting weight-loss drugs or a diet can cause weight regain—two strategies could help prevent that Scientific American
Is There a Generic for Zepbound? - Ro
Is There a Generic for Zepbound? Ro
Eli Lilly launches new form of obesity drug Zepbound with a month’s worth of doses in one pen - CNBC
Eli Lilly launches new form of obesity drug Zepbound with a month’s worth of doses in one pen CNBC
How To Get Zepbound: Eligibility Criteria And Where To Buy - Forbes
How To Get Zepbound: Eligibility Criteria And Where To Buy Forbes
Multi-Dose KwikPen Now Available for Zepbound Administration - Gastroenterology Advisor
Multi-Dose KwikPen Now Available for Zepbound Administration Gastroenterology Advisor
Amazon Pharmacy Expands Access to Eli Lilly’s Zepbound KwikPen for Weight Management - Yahoo Finance
Amazon Pharmacy Expands Access to Eli Lilly’s Zepbound KwikPen for Weight Management Yahoo Finance
FDA wants to limit knockoff versions of weight loss drugs like Ozempic and Zepbound - NBC News
FDA wants to limit knockoff versions of weight loss drugs like Ozempic and Zepbound NBC News
White House strikes deals for lower prices on obesity drugs - NPR
White House strikes deals for lower prices on obesity drugs NPR
Human Resources — Benefits shares four updates about prescription plan - Purdue University
Human Resources — Benefits shares four updates about prescription plan Purdue University
Eli Lilly Launches Zepbound KwikPen Multi-Dose Tirzepatide Pen for Adults With Obesity - HCPLive
Eli Lilly Launches Zepbound KwikPen Multi-Dose Tirzepatide Pen for Adults With Obesity HCPLive
Lilly's Taltz (ixekizumab) and Zepbound (tirzepatide) used together delivered superior efficacy in first-of-its-kind Phase 3b trial for adults with psoriasis and obesity or overweight - investor.lilly.com
Lilly's Taltz (ixekizumab) and Zepbound (tirzepatide) used together delivered superior efficacy in first-of-its-kind Phase 3b trial for adults with psoriasis and obesity or overweight investor.lilly.com
US weight-loss drugmakers slash prices in fight to win customers - BBC
US weight-loss drugmakers slash prices in fight to win customers BBC